Inograft Biotherapeutics
United States
unknown
unknown
Stage
1
Investors
About
Developer of novel non-genotoxic conditioning regimens designed to improve hematopoietic stem cell transplantation outcomes.
Explore Inograft Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.